New WHO Guidelines For Emergency Drug Donations

12 May 1996

New guidelines for drug donations during international emergencies have been issued by the World Health Organization.

The guidelines, which came in response to requests from relief organizations, call for drugs sent to emergencies to have a shelf life of at least a year, be clearly marked and be relevant. The guidelines are meant to ensure maximum benefit to the recipients and cut down on double standards in quality of drugs sent, noted the WHO; if a drug was not good enough to be used in the donor country it should not be sent elsewhere. In some disaster areas, donated drugs did more harm than good, it added.

Problems caused by previous donations, and cited by Reuters, include:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight